Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study

Author:

Bavendiek Udo1,Berliner Dominik1,Dávila Lukas Aguirre2,Schwab Johannes3,Maier Lars4,Philipp Sebastian A.5,Rieth Andreas6,Westenfeld Ralf7,Piorkowski Christopher8,Weber Kristina2,Hänselmann Anja1,Oldhafer Maximiliane1,Schallhorn Sven1,von der Leyen Heiko9,Schröder Christoph10,Veltmann Christian1,Störk Stefan11,Böhm Michael12,Koch Armin2,Bauersachs Johann1,Bavendiek Udo,Bauersachs Johann,Koch Armin,von der Leyen Heiko,Veltmann Christian,Böhm Michael,Störk Stefan,Tebbe Ulrich,von Haehling Stephan,Haass Markus,Anker Stefan,Mohacsi Paul,Pölzl Gerhard,Trampisch Helmut,Dávila Lukas Aguirre,Weber Kristina,Zimmermann Silke,Neuhaus Barbara,

Affiliation:

1. Department of Cardiology and AngiologyHannover Medical School Hannover Germany

2. Department of BiostatisticsHannover Medical School Hannover Germany

3. Department of Cardiology, Cardiovascular Center, Clinical Center NuernbergParacelsus Medical University Nuernberg Germany

4. Department of Internal Medicine IIUniversity Medical Center Regensburg Regensburg Germany

5. Department of Cardiology and Intensive Care MedicineElbe Clinic Stade Stade Germany

6. Department of Cardiology, Kerckhoff HeartRheuma and Thoracic Center Bad Nauheim Germany

7. Department of Cardiology, Pulmonology, and Vascular Medicine, Medical FacultyUniversity Duesseldorf Duesseldorf Germany

8. Department of Electrophysiology, Heart CenterUniversity of Technology Dresden Dresden Germany

9. Hannover Clinical Trial Centre Hannover Germany

10. Institute of Clinical PharmacologyHannover Medical School Hannover Germany

11. Department of Internal Medicine IUniversity Hospital Wuerzburg Wuerzburg Germany

12. Department of Internal Medicine IIIUniversity Hospital of the Saarland Homburg Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3